Literature DB >> 22217142

Eleven-year surveillance of antibiotic resistance in Streptococcus pneumoniae in Casablanca (Morocco).

Mohamed Benbachir1, Naima Elmdaghri, Houria Belabbes, Ghizlane Haddioui, Hanane Benzaid, Bahija Zaki.   

Abstract

OBJECTIVE: To analyze trends of antibiotic resistance rates in Streptococcus pneumoniae from 1998 to 2008 in Casablanca (Morocco).
METHODS: The antibiotic resistance levels of 955 consecutive nonduplicate isolates were studied using E test and disc diffusion methods. Results were interpreted following Clinical and Laboratory Standards Institute guidelines (2005). Analysis was done according to three periods (1998-2001; 2002-2005; 2006-2008), age, and site of infection.
RESULTS: Penicillin nonsusceptibility (PNS) increased significantly over time (15.6%, 17.8%, and 24.8%; p=0.003). Levels of PNS have changed as well: in 2006-2008, 9.1% of the isolates had an MIC ≥2 μg/ml versus 7.7% in 2002-2005 and 3.4% in 1998-2001. The PNS increase was particularly marked in pediatric isolates (21.4%, 25.5%, and 43.3%; p=0.001). There was no significant difference between the rates of PNS in invasive and noninvasive isolates from children, whereas in adults noninvasive isolates were more penicillin nonsusceptible. Amoxicillin and ceftriaxone nonsusceptible isolates were very rare. An increase of resistance rates was also noticed for erythromycin (9.4%, 12.2%, and 14.4%), tetracycline (20%, 18.6%, and 30.5%), and chloramphenicol (5.6%, 5.6%, and 8.1%). Trimethoprim-sulfamethoxazole resistance rates remained stable (22.8%, 20%, and 23.8%). Proportions of dual nonsusceptibility to penicillin and erythromycin, increased from 5.6% to 8.9%. Multiple drug resistance (resistance to 3 or more antibiotic classes) was found in 0%, 2.4%, and 7.7% of all isolates, respectively.
CONCLUSION: The results reported here maybe useful for guiding update of treatment recommendations and suggest the need for continuous surveillance. Increase of antibiotic resistance correlated with antibiotic consumption, stressing the need for elaboration of antibiotic policy in Morocco.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22217142     DOI: 10.1089/mdr.2011.0130

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  5 in total

1.  Evolution of antimicrobial resistance and serotype distribution of Streptococcus pneumoniae isolated from children with invasive and noninvasive pneumococcal diseases in Algeria from 2005 to 2012.

Authors:  N Ramdani-Bouguessa; H Ziane; S Bekhoucha; Z Guechi; A Azzam; D Touati; M Naim; S Azrou; M Hamidi; A Mertani; A Laraba; T Annane; S Kermani; M Tazir
Journal:  New Microbes New Infect       Date:  2015-03-26

2.  Analysis of amino acid motif of penicillin-binding proteins 1a, 2b, and 2x in invasive Streptococcus pneumoniae nonsusceptible to penicillin isolated from pediatric patients in Casablanca, Morocco.

Authors:  Idrissa Diawara; Kaotar Nayme; Khalid Katfy; Abouddihaj Barguigua; Mohamed Kettani-Halabi; Houria Belabbes; Mohammed Timinouni; Khalid Zerouali; Naima Elmdaghri
Journal:  BMC Res Notes       Date:  2018-08-31

Review 3.  Antimicrobial resistance among GLASS pathogens in Morocco: an epidemiological scoping review.

Authors:  Chakib Nejjari; Youness El Achhab; Amina Benaouda; Chakib Abdelfattah
Journal:  BMC Infect Dis       Date:  2022-05-07       Impact factor: 3.667

4.  Antibiotic Usage Prior and During Hospitalization for Clinical Severe Pneumonia in Children under Five Years of Age in Rabat, Morocco.

Authors:  Imane Jroundi; Rachid Benmessaoud; Chafiq Mahraoui; Cinta Moraleda; Houssain Tligui; Myriam Seffar; Badr Sououd Benjelloun; Jordi Vila; Joaquim Ruiz; Pedro L Alonso; Quique Bassat
Journal:  Antibiotics (Basel)       Date:  2013-09-26

5.  Risk factors for a poor outcome among children admitted with clinically severe pneumonia to a university hospital in Rabat, Morocco.

Authors:  Imane Jroundi; Chafiq Mahraoui; Rachid Benmessaoud; Cinta Moraleda; Houssain Tligui; Myriam Seffar; Salma Ech-Cherif El Kettani; Badr Sououd Benjelloun; Saad Chaacho; Carmen Muñoz-Almagro; Joaquim Ruiz; Pedro L Alonso; Quique Bassat
Journal:  Int J Infect Dis       Date:  2014-10-08       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.